AUSTAR Group and Sentronic GmbH Partner to Provide NIR-based PAT Solutions for OSD Manufacturers

AUSTAR is a technology-based pharmaceutical engineering solution provider with a deep understanding of industry regulations and processes. Integrating global high-quality resources and being committed to helping clients improve process and operational effectiveness. Through boosting global drug safety and efficacy to protect and promote human health.

Sentronic has almost 25 years of experience in spectroscopy. As one of the first partners to help users realize inline measurements as part of the FDA PAT initiative in 2003, it has established the basis for turnkey solutions using near infrared spectroscopy. With a strong focus on applications in diffuse reflectance, the typical unit operations in batch and continuous processing can be monitored in real time. Based on the powerful SentroPAT system series, Sentronic offers solutions to realize PAT in all phases, from early process and product development, process transfer to routine operation, and also process troubleshooting.

With the final signatures under a strategic partnership agreement, AUSTAR and Sentronic GmbH will join forces to enhance the application of PAT products and technical services in OSD research and manufacturing, and continuously upgrade CM technology and services for pharmaceutical clients with high-quality OSD process systems.